Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Neon Therapeutics
4370
Neon Therapeutics
Health Care
Technology
Biotechnology
Neon Therapeutics is an immunooncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer.
Suggest edits
Type
B2c
Founded
2015
Raised
$161M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
Breath Therapeutics Holding
Bioverativ
Aelix Therapeutics
NetVation
NorthSea Therapeutics
BioMark Health
Cavidi
Ackerman Boitech
InSitu Biologics
Iota Biosciences
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$36,000,000
Venture capital (Series B) - 2017
Access Industries
Hillhouse Capital Group
Wellington Management
+6
$70,000,000
Venture capital (Series B) - 2017
Access Industries
Wellington Management
Fidelity Management and Research Company
+4
Team Size
10+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Xconomy
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal
PE HUB
VC-backed Neon Therapeutics goes public
Stock markets
Costs
Health
Xconomy
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines
Health
Science
$70,000,000
Venture capital (Series B)
businesswire
Neon Therapeutics Secures $70 Million in Series B Financing | Business Wire
$55,000,000
Venture capital (Series A)
FinSMEs
Neon Therapeutics Raises $55M Series A Financing
